KONAKION MM PAEDIATRIC Solution (ampoules) (2019)
Βιβλιογραφική αναφορά
Για την προβολή της πλήρους καταχώρησης απαιτείται συνδρομή σε ισχύ.
Αποκτήστε πρόσβαση σε όλες τις πληροφορίες και τα εργαλεία του Galinos.gr δωρεάν για έναν μήνα απλά κάνοντας εγγραφή.
Δωρεάν εγγραφή
Αποκτήστε πρόσβαση σε όλες τις πληροφορίες και τα εργαλεία του Galinos.gr δωρεάν για έναν μήνα απλά κάνοντας εγγραφή.
Δωρεάν εγγραφή
Περιεχόμενα
Name of the medicinal product
Konakion MM Paediatric.
Qualitative and quantitative composition
Each ampoule contains 2mg phytomenadione in 0.2ml.
Pharmaceutical form
The ampoule solution is clear to slightly opalescent, pale yellow in colour and contains the active constituent in a mixed micelles vehicle of glycocholic acid and lecithin.
Therapeutic indications
Konakion MM Paediatric is indicated for the prophylaxis and treatment of vitamin K deficiency bleeding (VKDB) in neonates and infants. Konakion MM Paediatric can be used, following specialist advice from ...
Posology and method of administration
Prophylaxis of vitamin K deficiency bleeding (VKDB) Healthy neonates of 36 weeks gestation and older: Either: 1 mg administered by intramuscular injection at birth or soon after birth or 2 mg orally at ...
Contraindications
Use in patients with a known hypersensitivity to any of the constituents.
Special warnings and precautions for use
At the time of use, the ampoule contents should be clear. Following incorrect storage, the contents may become turbid or present a phase-separation. In this case the ampoule must no longer be used. Parenteral ...
Interaction with other medicinal products and other forms of interaction
No significant interactions are known other than antagonism of coumarin anticoagulants.
Pregnancy and lactation
Not applicable.
Effects on ability to drive and use machines
Not applicable.
Undesirable effects
There have been reports of anaphylactoid reactions after intravenous injections of Konakion MM. Local irritation may occur at the injection site but is unlikely due to the small injection volume. Rarely, ...
Overdose
There is no known clinical syndrome attributable to hypervitaminosis of vitamin K<sub>1</sub>. The following adverse events have been reported concerning overdose with use of Konakion in neonates and infants: ...
Pharmacodynamic properties
Pharmacotherapeutic group: Antihaemorrhagics (vitamins) ATC code: B02BA01 Konakion MM is a preparation of synthetic phytomenadione (vitamin K<sub>1</sub>). The presence of vitamin K<sub>1</sub> is essential ...
Pharmacokinetic properties
In the mixed micelle solution, vitamin K<sub>1</sub> is solubilised by means of a physiological colloidal system consisting of lecithin and a bile acid. Following oral administration vitamin K<sub>1</sub> ...
Preclinical safety data
None applicable.
List of excipients
Glycocholic acid Lecithin Sodium hydroxide Hydrochloric acid Water
Incompatibilities
Incompatibilities have been observed with diluted Konakion MM solution and certain siliconised syringes, therefore, Konakion MM Paediatric must not be diluted before injection. Do not dilute with sodium ...
Shelf life
Shelf life: 3 years.
Special precautions for storage
Konakion MM Paediatric Ampoule solution should be stored below 25°C and be protected from light. The solution should not be frozen. Do not use if the solution is turbid.
Nature and contents of container
Amber glass ampoules containing 2 mg phytomenadione in 0.2 ml. Plastic oral dispensers. Packs of 5.
Special precautions for disposal and other handling
See section 4.2 Posology and method of administration, section 4.4 Special warnings and precautions for use and section 6.2 Incompatibilities for advice regarding the administration of Konakion MM Paediatric. ...
Marketing authorization holder
CHEPLAPHARM Arzneimittel GmbH, Ziegelhof 24, 17489 Greifswald, Germany
Marketing authorization number(s)
PL 27041/0010
Date of first authorization / renewal of the authorization
20/06/1996 / 11/03/2008
Date of revision of the text
22/02/2019
Πηγαίο έγγραφο
Το πηγαίο έγγραφο για αυτήν την βιβλιογραφική αναφορά είναι διαθέσιμο προς μεταφόρτωση:
